[ARS] Inhibikase Therapeutics, Inc. SEC Filing Filing Impact (Low) Filing Sentiment (Neutral) Form Type ARS 04/30/2026 - 04:15 PM ⛶ Fullscreen ARS - Inhibikase Therapeutics, Inc. ARS Filing - Inhibikase Therapeutics, Inc. This filing is available as a PDF document. Filing Type: ARS Company: Inhibikase Therapeutics, Inc. (IKT) Acceptance Date: 2026-04-30T16:15:02.000Z View PDF Document Source: View Original Filing on SEC EDGAR
